• AMNOG-Monitor
  • Overview
    • Results of the early benefit assessment
      • G-BA procedures
      • Resolutions
      • Subpopulations
      • Patients
    • Indication areas (G-BA)
      • Eye diseases
      • Skin diseases
      • Cardiovascular diseases
      • Infectious diseases
      • Respiratory system diseases
      • Hematopoietic diseases
      • Musculoskeletal system diseases
      • Nervous system diseases
      • Genitourinary system diseases
      • Digestive system diseases
      • Oncological diseases
      • Mental illnesses
      • Other diseases
      • Metabolic diseases
      • Orphan Drugs
    • Special constellations
      • Orphan drugs
      • ATMP
      • ATMP CAR-T cells
      • PUMA
      • Evidence transfer
      • Reserve antibiotics
      • Conditional marketing authorisation
      • Approval under exceptional circumstances
      • Accelerated assessment
      • New data protection
      • Procedures without a dossier
    • Results of reassessments
      • Limitation
      • G-BA request (§13 VerfO)
      • Manufacturer's request (§14 VerfO)
      • Orphan drugs, exceeding turnover limit
      • Orphan drugs, loss of status
    • G-BA requirements
      • Accompanying data collection (AbD)
      • Quality requirements for ATMP
      • Bundling
      • Repealed resolutions
  • Procedures
    • G-BA Resolutions
    • G-BA active procedures
    • G-BA procedures not completed
    • EMA CHMP positive opinions
  • Reimbursement prices
    • Recent price changes
    • Arbitration results
    • Discontinuations
    • Special practice conditions
    • AM-RL Appendix III: Prescription exclusions
    • AM-RL Appendix VI: Off-label Use
    • AM-RL Appendix VIIa: Biosimilars
    • AM-RL Appendix XIIa: Combination discounts
  • Interactive analysis
    • Resolutions
    • Subpopulations
    • All Procedures (active+resolutions)
  • Intelligent Search
  • EU HTA Monitor
    • Overview
    • EU-NETHA Pilot Projects
    • Joint Clinical Assessments
    • PICO Exercises
    • Legal Framework
  • Fundamentals
    • AMNOG Monitor step by step
      • Detailed analysis for each G-BA resolution
      • Interactive analysis
      • Interactive analysis: Excel export
      • Interactive analysis: Bookmarks
      • Interactive analysis: dimensions
      • Intelligent search
      • Monthly report
      • AMNOG Monitor app
      • Calculation methods
    • EMA regulatory procedure
    • Changes in legal regulations
    • Technical terms English-German
  • Contact
    • Contact form
    • Legal notice
    • Privacy policy
    • Terms of Use
    • Partnership Register
Logo AMNOG-Monitor.com
Beschluss-Suche

Anmelden

Anmelden
  • Deutsch
  • English

Passwort vergessen?

Falls Sie Ihr Passwort nicht mehr parat haben, geben Sie unten Ihre E-Mail-Adresse ein. Wir senden Ihnen einen Link zum Zurücksetzen Ihres Passworts.

Zurück zur Anmeldung


AMNOG Monitor ·  Impressum ·  Dr. Hankowitz & Partner – Arzt und Apotheker ·  www.amnog-monitor.com